Kite Appoints Frank Neumann as Worldwide Head of Clinical Development

Go back to Kite Appoints Frank Neumann as Worldwide Head of Clinical Development
Gilead Sciences (NASDAQ: GILD) Delayed: 125.60 -0.27 (0.21%)
Previous Close $125.87    52 Week High $108.63 
Open $126.13    52 Week Low $71.39 
Day High $126.51    P/E 69.39 
Day Low $124.29    EPS $1.81 
Volume 3,935,828